Literature DB >> 19356618

Contribution of IRF-3 mediated IFNbeta production to DNA vaccine dependent cellular immune responses.

Hidekazu Shirota1, Lev Petrenko, Toshio Hattori, Dennis M Klinman.   

Abstract

The mechanism(s) by which DNA vaccines activate Ag-specific cellular immune responses is incompletely understood. Current findings indicate that IRF-3 plays an important role in this process. The IRF-3 dependent signaling pathway is triggered by the presence of intracytoplasmic DNA, and culminates in the production of type I IFNs. DNA vaccination of IRF-3 KO mice elicits a strong Ag-specific humoral response, yet CD4 and CD8 T cell responses (including the production of Th1, Th2 and Th 17 cytokines) are severely impaired. Although expression of the immunogenic protein encoded by the DNA vaccine was similar in IRF-3 KO vs wild type mice, antigen presentation was severely impaired in the KO animals. This defect was remedied by the co-delivery of an IFNbeta encoding plasmid. These findings suggest that the IRF-3/IFNbeta pathways are key to the induction of cellular immunity following DNA vaccination.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19356618      PMCID: PMC2667800          DOI: 10.1016/j.vaccine.2009.01.134

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  28 in total

Review 1.  DNA vaccines: immunology, application, and optimization*.

Authors:  S Gurunathan; D M Klinman; R A Seder
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Regulation of T-helper type 2 cell and airway eosinophilia by transmucosal coadministration of antigen and oligodeoxynucleotides containing CpG motifs.

Authors:  H Shirota; K Sano; T Kikuchi; G Tamura; K Shirato
Journal:  Am J Respir Cell Mol Biol       Date:  2000-02       Impact factor: 6.914

Review 3.  Recognition of viruses by innate immunity.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Immunol Rev       Date:  2007-12       Impact factor: 12.988

4.  Potential of transfected muscle cells to contribute to DNA vaccine immunogenicity.

Authors:  Hidekazu Shirota; Lev Petrenko; Choongman Hong; Dennis M Klinman
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

Review 5.  DNA and RNA-based vaccines: principles, progress and prospects.

Authors:  W W Leitner; H Ying; N P Restifo
Journal:  Vaccine       Date:  1999-12-10       Impact factor: 3.641

6.  Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction.

Authors:  M Sato; H Suemori; N Hata; M Asagiri; K Ogasawara; K Nakao; T Nakaya; M Katsuki; S Noguchi; N Tanaka; T Taniguchi
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

7.  IRF-3-dependent, NFkappa B- and JNK-independent activation of the 561 and IFN-beta genes in response to double-stranded RNA.

Authors:  Kristi L Peters; Heather L Smith; George R Stark; Ganes C Sen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

8.  Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice.

Authors:  Barbara Spies; Hubertus Hochrein; Martin Vabulas; Katharina Huster; Dirk H Busch; Frank Schmitz; Antje Heit; Hermann Wagner
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

9.  CD28, TNF receptor, and IL-12 are critical for CD4-independent cross-priming of therapeutic antitumor CD8+ T cells.

Authors:  Hong-Ming Hu; Hauke Winter; Jun Ma; Michael Croft; Walter J Urba; Bernard A Fox
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

10.  TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines.

Authors:  Ken J Ishii; Tatsukata Kawagoe; Shohei Koyama; Kosuke Matsui; Himanshu Kumar; Taro Kawai; Satoshi Uematsu; Osamu Takeuchi; Fumihiko Takeshita; Cevayir Coban; Shizuo Akira
Journal:  Nature       Date:  2008-02-07       Impact factor: 49.962

View more
  7 in total

1.  Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine.

Authors:  Jeremy M Luke; Gregory G Simon; Jonas Söderholm; John S Errett; J Thomas August; Michael Gale; Clague P Hodgson; James A Williams
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

Review 2.  DNA vaccines for prostate cancer.

Authors:  Christopher D Zahm; Viswa Teja Colluru; Douglas G McNeel
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

3.  Oligodeoxynucleotides expressing polyguanosine motifs promote antitumor activity through the upregulation of IL-2.

Authors:  Nobuaki Kobayashi; Choongman Hong; Dennis M Klinman; Hidekazu Shirota
Journal:  J Immunol       Date:  2013-01-07       Impact factor: 5.422

4.  NF-κB activation during intradermal DNA vaccination is essential for eliciting tumor protective antigen-specific CTL responses.

Authors:  Maarten A Ligtenberg; Nicole Rojas-Colonelli; Rolf Kiessling; Alvaro Lladser
Journal:  Hum Vaccin Immunother       Date:  2013-07-24       Impact factor: 3.452

5.  A cGAS-Independent STING/IRF7 Pathway Mediates the Immunogenicity of DNA Vaccines.

Authors:  John J Suschak; Shixia Wang; Katherine A Fitzgerald; Shan Lu
Journal:  J Immunol       Date:  2015-11-20       Impact factor: 5.422

Review 6.  Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination.

Authors:  Kouji Kobiyama; Nao Jounai; Taiki Aoshi; Miyuki Tozuka; Fumihiko Takeshita; Cevayir Coban; Ken J Ishii
Journal:  Vaccines (Basel)       Date:  2013-07-18

Review 7.  DNA vaccines: a simple DNA sensing matter?

Authors:  Cevayir Coban; Kouji Kobiyama; Nao Jounai; Miyuki Tozuka; Ken J Ishii
Journal:  Hum Vaccin Immunother       Date:  2013-08-02       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.